AnandRathi

FDC Ltd Share Price

Last Updated Date: 27 Aug 2026
343.70
-4.80 (-1.38%)

As of 28 Aug 2026, FDC Ltd share price is ₹343.70. The stock opened at ₹343.70 and had closed at ₹348.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹314.75 and a high of ₹528.30. In terms of performance, FDC Ltd share price has decreased by 4.81% over the past six months and has decreased by 23.75% over the last year.

FDC Charts

FDC Ltd Overview

Market cap₹5,674 Crs
Volume3,114
Prev. Close₹348.50
Year range₹314.75 - ₹528.30
Total Value₹10,70,281.80
ISININE258B01022

About FDC

FDC in the business of manufacturing and trading of pharmaceutical products.

FDC Ltd Historical Performance

1 Month Return-16.49%
6 Month Return-4.49%
3 Year Return-8.70%
3 Month Return-13.67%
1 Year Return-24.37%
5 Year Return0.11%

FDC Ltd Fundamental Analysis

ROCE(TTM)15.28%
P/E Ratio (TTM)19.18
P/B Ratio2.28
Debt to Equity0.01
ROE11.47%
EPS (TTM)19.10
Dividend Yield1.43%
Book Value153.10
Profit Margin14.54%
Operating Margin13.07%

FDC Ltd Financials

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25
Revenue702.44611.53480.01482.65677.87
EBITDA190.18158.7750.8955.81176.92
Net Profit132.02107.0727.1929.48122.20
EPS8.116.581.671.817.51

FDC Ltd Technical Analysis

IndicatorValue
RSI32.15
MACD-15.54
20-Day SMA366.25

FDC Ltd Corporate Actions

Corporate ActionEx DateRecord Date
No forthcoming board meetings available.

FDC Ltd Peer Comparison

CompanyPriceM.Cap (Cr)P/E (TTM)ROE (TTM)
Sun Pharmaceutical Industries LtdSUNPHARMA
1,913.30+0.73%
4,19,727.6638.3213.74%
Divis Laboratories LtdDIVISLAB
9,060.00+0.39%
1,67,235.9167.4615.32%
Torrent Pharmaceuticals LtdTORNTPHARM
4,999.00+2.23%
1,46,951.3264.6825.49%

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research